Lecture 1 - Urinary Incontinence & BPH Flashcards
Who is urinary incontinence more common in?
Women, due to having babies
Reversible causes & Management of incontinence…DRIIPP
Delirium
Restricted mobility, injury, restraint
Infection
Stool Impaction
Polyuria
Pharmaceuticals
Urge Urinary Incontinence (UUI)
involuntary voiding preceded by brief warning
Causes: Detrusor muscle instability, involuntary contraction
Overactive bladder = w/ or w/o urge incontinence
UUI Treatment
Nonpharm = 1st (Lifestyle/ Surgery)
Pharm = 4-6 week response, switch if no response
Non-pharm Treatment UUI
Diet = monitor fluid, caffeine, bladder irritants (artificial sweetener, spicy food)
Exercise and weight loss
Smoking cessation
Scheduling regimens
Muscle Rehab
Surgery
UUI Treatment, Anticholingeric side effects
Dry mouth
visual disturbances
Constipation
Dry skin
UUI Treatment, Anticholinergic precautions
Arrythmias
CVD
GI issues
Dementia
elderly
UUI Treatment, Anticholinergic precautions CI
GI obstruction
closed & narrow angle glaucoma
Toxidrome Poem for Anticholinergic
Blind as a bat
Mad as a hatter
Red as a beet
Hot as a hare
Dry as a bone
The bowel and bladder lose their tone
and the heart runs alone
Solifenacin Info
M3 selectivity > M2
non-inferior to oxybutynin, superior to tolterodine
SE: less than oxybutynin/tolterodine, more than darifenacin
Dose: 5mg/day max, renal impairment < 30, mod/severe hepatic impairment
Darifenacin info
truly selective M3
non inferior oxybutynin,superior tolterodine
SE: less than oxybutynin
Dose: no renal dose adjust, if moderate hepatic impairment then max 7.5mg/day
UUI Treatment efficacy
Doesn’t decrease events by much
most agents used 4-8 weeks to see effect
continuation rats drop drastically over time
Mirabegron (Myrbetriq) drug class
B3 agonist
Mirabegron (Myrbetriq) Drug interactions
moderate CYP2D6
substate of 2D6, 3A4, p-gp
Mirabegron (Myrbetriq) Dosing
50mg/day
25mg/day if eGFR 15-30
Not studied < 15
Mirabegron (Myrbetriq) SE/CI
HTN (avoid if severe, uncontrolled > 180/110)
Nasopharyngitis
UTI
Constipation
Tachycardia
Headache
Mirabegron (Myrbetriq) efficacy
Full effect in 4-8 weeks
Good in combo w/ solifenacin but more SE
Vibegron (Gemetsa) drug class
B3-agonist